InCephalo Therapeutics

Switzerland
Allschwil, Basel-Landschaft, Switzerland

Company profile

InCephalo Therapeutics company profile

InCephalo Therapeutics is a preclinical stage biotech company developing local treatments for neurological diseases with a focus on cancers in the brain. The company's C-Lock or Compartment Lock technology retains biologics, that are applied locally behind the blood-brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrade rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2021-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Articles
1

Founders and investors

No public relation records are available.